Dextrose and Sodium Chloride · DEXTROSE MONOHYDRATE 5 g/100mL; SODIUM CHLORIDE 900 mg/100mL · Injection, Solution · Intravenous · Baxter Healthcare Company
NDC 00338-0089-03 · 24 BAG in 1 CARTON / 500 mL in 1 BAG · NDA · View full market →
Just 2 companies supply this market — thin enough that a single exit would be felt immediately. One of its named manufacturing plants, Baxter Healthcare Corporation, failed FDA inspectionwithin the last two years — the agency’s most serious outcome.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Matched to CMS's representative package for this drug (NDC 00338-0089-04) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 5 quarters since 2024.
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Not scored — fragility is computed for NADAC-priced NDCs.
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| B. Braun Medical Inc. | DEXTROSE, UNSPECIFIED FORM 5 g/100mL; SODIUM CHLORIDE .9 g/100mL | Jul 15, 2026 | Sep 2, 2026 |
| B. Braun Medical Inc. | DEXTROSE, UNSPECIFIED FORM 3.3 g/100mL; SODIUM CHLORIDE .3 g/100mL | Jul 15, 2026 | Sep 2, 2026 |
| B. Braun Medical Inc. | DEXTROSE, UNSPECIFIED FORM 5 g/100mL; SODIUM CHLORIDE .2 g/100mL | Jul 15, 2026 | Sep 2, 2026 |
| B. Braun Medical Inc. | DEXTROSE, UNSPECIFIED FORM 5 g/100mL; SODIUM CHLORIDE .33 g/100mL | Jul 15, 2026 | Sep 2, 2026 |
| B. Braun Medical Inc. | DEXTROSE, UNSPECIFIED FORM 5 g/100mL; SODIUM CHLORIDE .45 g/100mL | Jul 15, 2026 | Sep 2, 2026 |
| B. Braun Medical Inc. | DEXTROSE, UNSPECIFIED FORM 10 g/100mL; SODIUM CHLORIDE .2 g/100mL | Jul 15, 2026 | Sep 2, 2026 |
| B. Braun Medical Inc. | DEXTROSE, UNSPECIFIED FORM 10 g/100mL; SODIUM CHLORIDE .45 g/100mL | Jul 15, 2026 | Sep 2, 2026 |
| Baxter Healthcare Company | DEXTROSE MONOHYDRATE 5 g/100mL; SODIUM CHLORIDE 200 mg/100mL | Jul 15, 2026 | Sep 2, 2026 |
| Baxter Healthcare Company | DEXTROSE MONOHYDRATE 5 g/100mL; SODIUM CHLORIDE 450 mg/100mL | Jul 15, 2026 | Sep 2, 2026 |
| Baxter Healthcare Company | DEXTROSE MONOHYDRATE 5 g/100mL; SODIUM CHLORIDE 900 mg/100mL | Jul 15, 2026 | Sep 2, 2026 |
| Baxter Healthcare Company | DEXTROSE MONOHYDRATE 2.5 g/100mL; SODIUM CHLORIDE 450 mg/100mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Dextrose and Sodium Chloride — NDC 00338-0089-03," retrieved September 3, 2026, https://drugdashboards.com/drug/00338008903.
Free to cite with attribution — see how the data is put together.